You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

Citation Tools

Article menu

This article has a correction. Please see:

Download PDFPDF

Psoriatic arthritis
Original research
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
McInnes IB, Kato K, Magrey M, et al
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study
RMD Open 2021;7:e001838. doi: 10.1136/rmdopen-2021-001838